Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease.
about
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processesSubstantia nigra neuromelanin: structure, synthesis, and molecular behaviourInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseAlpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface.D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics.Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeysNeuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigraNeuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra.X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues.Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease.Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.Eryptosis as a marker of Parkinson's diseaseChronic nicotine treatment increases nAChRs and microglial expression in monkey substantia nigra after nigrostriatal damageBasal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.Stem cell therapy for Parkinson's disease.Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonismHeterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain.Quantitative T1, T2, and T2* Mapping and Semi-Quantitative Neuromelanin-Sensitive Magnetic Resonance Imaging of the Human Midbrain.Modifications of the iron-neuromelanin system in Parkinson's disease.γ-Glutamylamines and neurodegenerative diseasesAlpha-synuclein and Parkinson's disease: a proteomic view.Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.Future of cell and gene therapies for Parkinson's disease.Characterization of a Novel Monoclonal Antibody against Human Mitochondrial Ferritin and Its Immunohistochemical Application in Human and Monkey Substantia Nigra.Vulnerability of mesostriatal dopaminergic neurons in Parkinson's diseaseNeuronal vulnerability, pathogenesis, and Parkinson's diseaseThe pathology roadmap in Parkinson disease.Neuronal vulnerability, pathogenesis, and Parkinson's disease.Neuromelanin of the human substantia nigra: an update.Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity.In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.Dual effects of TNFalpha on nerve fiber formation from ventral mesencephalic organotypic tissue cultures.Biosynthesis, structure, and function of neuromelanin and its relation to Parkinson's disease: a critical update.Habitual behavior and dopamine cell vulnerability in Parkinson disease.Expression of calbindin D28K in the dopaminergic mesotelencephalic system in embryonic and fetal human brain.Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei.
P2860
Q22337213-461C0C73-9ED8-4390-B27A-D4202DED432EQ28365463-72E6E4A1-F0B3-4115-8F95-15940B10B04FQ28391762-ABEA7B7A-C20E-4657-B46A-355B93B45594Q30856480-55BA1880-3A6B-4567-94F7-E8C478229339Q30859509-11452AC5-FBC1-4697-A229-6E1D5F430D53Q33258374-01540AD2-5E36-4B6A-B734-A60CD8C98801Q33692872-294E752A-09DB-429E-833F-7E44ABBA23BBQ33859902-AD7B78F9-34F3-479E-A8BC-7D31D1DDEDA9Q33922930-91BD5B41-3F6A-4344-B968-FE8B8158CA2CQ34098187-66D6DAFB-061F-4140-98AD-0B522006FD49Q34169019-854EA7DB-05A5-4C99-B097-24286AED9022Q34169679-161ABCED-5509-4918-A91C-D94036248FF3Q34327144-334B1607-AD56-49FF-AE08-5EBF479EAA67Q34416128-B9C9D1E0-C64F-4230-AC9B-D573AB7F094FQ34585744-2159AA26-80A7-4B5B-9F66-1724D8C2D529Q35098275-F76C6F90-D27C-4DA4-903B-BB90497295B9Q35208420-FD18498D-E460-4485-A4D2-99CE415CB90FQ35236822-E6E4D7BB-31EE-4046-B03C-F5BE44998158Q35455565-3C326E36-C17A-4629-AB44-77352D600D48Q36041480-963B29D5-012B-4068-9D15-496F1A25EAD5Q36171001-15930A8D-297F-4CB3-842F-6E1770BB62AAQ36370608-9DB11C7E-3CE6-495B-81A2-0FE2FA677AA1Q36377238-489693D3-2492-4453-B6DE-D93704B55930Q37157838-3E3954D3-B11B-4CEB-B374-845A3B88928AQ37200879-292856EA-9361-4447-9D92-A1A35BB749BFQ37485071-1E0BFB7C-121C-4072-8ADE-B4F40C959069Q37696495-F31510CD-2801-4900-B787-CE08E07232EBQ37730855-BC0043AD-78DE-4867-8657-17657C62A17CQ37809751-390E5267-FC01-4518-BD55-9CA03C63278FQ38026023-B178537D-20F1-44CE-8C64-4393B2D8D067Q38074519-E15AA3B4-8E93-48B5-881C-1179CBA2647BQ38099288-EAAFE68E-5A78-4B77-9435-BD4494C5E3CEQ38155132-19BB4D3B-1A4A-4630-A084-FD38AF186735Q39368224-96A3E3A0-6858-4597-AFDB-C327E19B6B4BQ39758264-97D05EBD-D624-4532-AA19-F675371A6D07Q41664422-0B7F6795-1232-4912-A8FC-99F13320A826Q41680664-375B962C-70F9-4513-AFEB-4B2334F6C5D4Q42177449-3AB3C43D-F240-43A6-B68E-1CB29920B622Q42496300-43A4C8A2-530E-4111-B2D7-97AAD4D06883Q42519458-B87CA8A4-15E0-4A95-A22A-E82D41BC04F4
P2860
Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Melanin, tyrosine hydroxylase, ...... bility in Parkinson's disease.
@en
Melanin, tyrosine hydroxylase, ...... bility in Parkinson's disease.
@nl
type
label
Melanin, tyrosine hydroxylase, ...... bility in Parkinson's disease.
@en
Melanin, tyrosine hydroxylase, ...... bility in Parkinson's disease.
@nl
prefLabel
Melanin, tyrosine hydroxylase, ...... bility in Parkinson's disease.
@en
Melanin, tyrosine hydroxylase, ...... bility in Parkinson's disease.
@nl
P921
P1433
P1476
Melanin, tyrosine hydroxylase, ...... bility in Parkinson's disease.
@en
P2093
P304
P356
10.1016/0006-8993(92)90719-P
P407
P577
1992-05-01T00:00:00Z